Amgen

American multinational biopharmaceutical company

AMGN Nasdaq · home listing 4332 Hong Kong Stock Exchange ISIN US0311621009 SEC CIK 318154 LEI 62QBXGPJ34PQ72Z12S66
Follow Amgen Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $10.4B +8.5% vs same quarter last year
Net income $3.9B +20.1% vs same quarter last year
EPS, diluted $7.08 +19.4% vs same quarter last year
Operating cash flow $4.2B −9.5% vs same quarter last year
Revenue by quarter
$9.1B
$8.1B
$9.2B
$9.6B
$9.9B
$8.6B
$10.1B
$10.4B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$10B$20B$30B$40BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$36.8B$7.7B
FY24$33.4B$4.1B
FY23$28.2B$6.7B
FY22$26.3B$6.6B
FY21$26B$5.9B
FY20$25.4B$7.3B
FY19$23.4B$7.8B
FY18$23.7B$8.4B
FY17$22.8B$2B
FY16$23B$7.7B
FY15$21.7B$6.9B
FY14$20.1B$5.2B
FY13$18.7B$5.1B
FY12$17.3B$4.3B
FY11$15.6B$3.7B
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%25%50%75%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2567.2%24.7%21%
FY2461.5%21.7%12.2%
FY2370%28%23.8%
FY2275.7%36.3%24.9%
FY2175.2%29.4%22.7%
FY2075.8%35.9%28.6%
FY1981.4%41.4%33.6%
FY1882.7%43.2%35.3%
FY1782.2%43.6%8.7%
FY1681.9%42.6%33.6%
FY1580.5%39.1%32%
FY1478%30.9%25.7%
FY1382.1%31.4%27.2%
FY1281.5%32.3%25.2%
FY1182.6%27.7%23.6%
Free cash flowOperating cash flow minus capital expenditure
$0$5B$10B$15BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$8.1B
FY24$10.4B
FY23$7.4B
FY22$8.8B
FY21$8.4B
FY20$9.9B
FY19$8.5B
FY18$10.6B
FY17$10.5B
FY16$9.6B
FY15$9.1B
FY14$8.2B
FY13$5.8B
FY12$5.2B
FY11$4.6B
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$10B$20B$30BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$5.1B$0
FY24$4.8B$200M
FY23$4.6B$0
FY22$4.2B$6.4B
FY21$4B$5B
FY20$3.8B$3.5B
FY19$3.5B$7.7B
FY18$3.5B$17.8B
FY17$3.4B$3.2B
FY16$3B$3B
FY15$2.4B$1.9B
FY14$1.9B$138M
FY13$1.4B$832M
FY12$1.1B$4.6B
FY11$500M$8.3B
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Amgen
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAmgenHealthcare median
FY2521%−30.6%
FY2412.2%−47%
FY2323.8%−58%
FY2224.9%−80.4%
FY2122.7%−71.9%
FY2028.6%−62.2%
FY1933.6%−46.3%
FY1835.3%−49.6%
FY178.7%−45.9%
FY1633.6%−36%
FY1532%−38.4%
FY1425.7%−35.5%
FY1327.2%−37.1%
FY1225.2%−29.1%
FY1123.6%−27.9%